1. Home
  2. NVRO vs GCTS Comparison

NVRO vs GCTS Comparison

Compare NVRO & GCTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVRO
  • GCTS
  • Stock Information
  • Founded
  • NVRO 2006
  • GCTS 1998
  • Country
  • NVRO United States
  • GCTS United States
  • Employees
  • NVRO N/A
  • GCTS N/A
  • Industry
  • NVRO Medical/Dental Instruments
  • GCTS Blank Checks
  • Sector
  • NVRO Health Care
  • GCTS Finance
  • Exchange
  • NVRO Nasdaq
  • GCTS Nasdaq
  • Market Cap
  • NVRO 139.0M
  • GCTS 113.6M
  • IPO Year
  • NVRO 2014
  • GCTS N/A
  • Fundamental
  • Price
  • NVRO $4.57
  • GCTS $2.52
  • Analyst Decision
  • NVRO Hold
  • GCTS Strong Buy
  • Analyst Count
  • NVRO 14
  • GCTS 1
  • Target Price
  • NVRO $7.97
  • GCTS $8.00
  • AVG Volume (30 Days)
  • NVRO 572.2K
  • GCTS 160.7K
  • Earning Date
  • NVRO 02-19-2025
  • GCTS 11-14-2024
  • Dividend Yield
  • NVRO N/A
  • GCTS N/A
  • EPS Growth
  • NVRO N/A
  • GCTS N/A
  • EPS
  • NVRO N/A
  • GCTS N/A
  • Revenue
  • NVRO $419,146,000.00
  • GCTS $11,532,000.00
  • Revenue This Year
  • NVRO N/A
  • GCTS N/A
  • Revenue Next Year
  • NVRO $0.64
  • GCTS $459.37
  • P/E Ratio
  • NVRO N/A
  • GCTS N/A
  • Revenue Growth
  • NVRO N/A
  • GCTS N/A
  • 52 Week Low
  • NVRO $3.17
  • GCTS $2.12
  • 52 Week High
  • NVRO $19.47
  • GCTS $56.00
  • Technical
  • Relative Strength Index (RSI)
  • NVRO 60.51
  • GCTS 52.26
  • Support Level
  • NVRO $3.17
  • GCTS $2.33
  • Resistance Level
  • NVRO $3.99
  • GCTS $2.51
  • Average True Range (ATR)
  • NVRO 0.33
  • GCTS 0.14
  • MACD
  • NVRO 0.13
  • GCTS 0.00
  • Stochastic Oscillator
  • NVRO 93.98
  • GCTS 56.36

About NVRO Nevro Corp.

Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.

About GCTS GCT Semiconductor Holding Inc. Common Stock

GCT Semiconductor Holding Inc. is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.

Share on Social Networks: